Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • ascls.org
    • ascls.org

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society for Clinical Laboratory Science
  • ascls.org
    • ascls.org
  • My alerts
  • Log in
  • My Cart
American Society for Clinical Laboratory Science

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Info for
    • Authors
    • Reviewers
  • About Us
    • About Us
    • Conflict of Interest
    • Informed Consent
    • Human and Animal Rights
  • More
    • Alerts
    • Feedback
    • Folders
  • Follow ASCLS on Twitter
  • Visit ASCLS on Facebook
  • Follow ASCLS on Instagram
  • RSS Feed
Research ArticleReports and Reviews

The Clinical Consequences and Diagnosis of Hypothyroidism

Vicky A LeGrys, Katherine Hartmann and Joan F Walsh
American Society for Clinical Laboratory Science October 2004, 17 (4) 203-208; DOI: https://doi.org/10.29074/ascls.17.4.203
Vicky A LeGrys
is Professor at University of North Carolina, Chapel Hill NC
DrA CLS(NCA)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: vlegrys@med.unc.edu
Katherine Hartmann
is Assistant Professor, Department of Epidemiology, University of North Carolina, Chapel Hill NC
MD PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joan F Walsh
is a Research Assistant, Sheps Center for Health Services Research, University of North Carolina, Chapel Hill NC
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

  1. Vicky A LeGrys, DrA CLS(NCA)⇑
    1. is Professor at University of North Carolina, Chapel Hill NC
  2. Katherine Hartmann, MD PhD
    1. is Assistant Professor, Department of Epidemiology, University of North Carolina, Chapel Hill NC
  3. Joan F Walsh, PhD
    1. is a Research Assistant, Sheps Center for Health Services Research, University of North Carolina, Chapel Hill NC
  1. Address for correspondence: Vicky A LeGrys DrA, Division of Clinical Laboratory Science, School of Medicine, University of North Carolina at Chapel Hill, Wing E 222H, CB # 7145, Chapel Hill NC 27599-7145. (919) 843-4473, (919) 966-8384 (fax). vlegrys{at}med.unc.edu

Extract

Thyroid dysfunction is the most prevalent endocrine disorder, affecting more than 21 million Americans. The annual healthcare costs known to be associated with thyroid dysfunction exceed 10 billion dollars annually.1 Manifestations of untreated thyroid dysfunction include coronary heart disease, osteoporosis, atrial fibrillation, cognitive impairment, and depression. These sequelae of undiagnosed thyroid dysfunction are among the major causes of mortality, morbidity, and diminished quality of life among older adults. In addition to the individual costs of such morbidity, including functional limitations and disruption of caring giving responsibilities, the healthcare costs associated with caring for individuals with heart disease, stroke, and hip fracture attributed to uncontrolled thyroid dysfunction are substantial. For example, coronary vascular disease (CVD) is the leading cause of mortality in developed countries, with more than 697,000 deaths in 1999 in the United States. In addition, CVD is a leading cause of morbidity, functional limitations, and reduced quality of life among affected individuals.2

Thyroid dysfunction can be divided into two general categories: 1) hyperthyroidism, characterized by increased thyroid hormones with decreased thyroid stimulating hormone (TSH) and 2) hypothyroidism, characterized by decreased thyroid hormones with increased TSH. Hypothyroidism is more common; between 10% to 20% of postmenopausal women have evidence of hypothyroidism which can have significant clinical consequences.3-7 Hypothyroidism can be further subdivided into overt and subclinical (mild) disorders. Because the signs and symptoms of hypothyroidism are vague and non-specific, many cases are not identified and go undiagnosed, prompting interest in routine screening for thyroid dysfunction. This article will review thyroid…

ABBREVIATIONS: CVD = coronary vascular disease; FT3 = free T3; FT4 = free T4; T3 = triiodothyronine; T4 = thyroxine; TPO = thyroid peroxidase; TPOAb = thyroid peroxidase antibody; TSH = thyroid stimulating hormone.

    INDEX TERMS
  • coronary vascular disease
  • hypothyroidism
  • © Copyright 2004 American Society for Clinical Laboratory Science Inc. All rights reserved.
PreviousNext
Back to top

In this issue

American Society for Clinical Laboratory Science: 17 (4)
American Society for Clinical Laboratory Science
Vol. 17, Issue 4
Fall 2004
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Society for Clinical Laboratory Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Clinical Consequences and Diagnosis of Hypothyroidism
(Your Name) has sent you a message from American Society for Clinical Laboratory Science
(Your Name) thought you would like to see the American Society for Clinical Laboratory Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Clinical Consequences and Diagnosis of Hypothyroidism
Vicky A LeGrys, Katherine Hartmann, Joan F Walsh
American Society for Clinical Laboratory Science Oct 2004, 17 (4) 203-208; DOI: 10.29074/ascls.17.4.203

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
The Clinical Consequences and Diagnosis of Hypothyroidism
Vicky A LeGrys, Katherine Hartmann, Joan F Walsh
American Society for Clinical Laboratory Science Oct 2004, 17 (4) 203-208; DOI: 10.29074/ascls.17.4.203
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Assessment of the Graduate Studies Background of CLS Faculty in University-based Programs
  • Polycystic Ovary (Stein-Leventhal) Syndrome: Etiology, Complications, and Treatment
Show more Reports and Reviews

Similar Articles

Keywords

  • coronary vascular disease
  • Hypothyroidism

© 2025 The American Society for Clinical Laboratory Science

Powered by HighWire